[ad_1]
A federal jury ruled Friday that Masimo smartwatches infringed Apple’s patents, but Apple didn’t get a big payday.
Bloomberg Law reports That the company was only going for the legal minimum of $250, and that’s all I got. “We’re not here for the money,” Apple lawyer John Desmarais reportedly told jurors. Instead, he said the company hopes to force Massimo to “stop copying our design.”
The company may have been disappointed on this front. The jury did finds That the original design of the Masimo W1 Freedom and health module, as well as the original charger, infringed Apple patents, and that the infringement was intentional.
However, Masimo noted in a statement that the findings only apply to a “discontinued unit and charger,” not its current products.
“Apple primarily sought an injunction against existing Masimo products, and the jury’s ruling is a victory for Masimo in this case,” the medical device company said.
The trial resulted from Apple’s countersuit in its ongoing legal battle with Masimo, which began with Masimo claiming that its patents were being infringed by the Apple Watch’s pulse oximetry feature, which allows watch owners to measure their blood oxygen levels. . Apple disabled the feature on the Apple Watch Series 9 and Ultra 2, and it’s also missing from the new Series 10. These restrictions apply only in the United States, where Apple is appealing an import ban on models with the disputed feature.
Desmeriers reportedly told the jury that the pulse oximetry feature was “irrelevant to this case.”
[ad_2]